Quartz · 15 Oct, 20:39 · Healthcare briefing

Eli Lilly stock gains more than 3% as investors shift from tech to healthcare

Eli Lilly shares rose over three per cent as investors increasingly favour healthcare stocks over technology equities.

31%salary uplift reported after healthcare management certification
13%projected growth in health services roles this decade
2.1xmore interview callbacks with a verified credential
20days to your first credential
The briefing

The story
in brief.

What happened, who it affects, and why it landed on our intelligence desk — in plain English, sixty seconds or less.

Eli Lilly shares rose over three per cent as investors increasingly favour healthcare stocks over technology equities. This market movement signals a broader rotation of capital away from the tech sector, which has dominated recent growth, towards pharmaceutical and health-focused businesses. The shift reflects changing investor sentiment regarding valuation and future earnings potential. For professionals, this indicates that healthcare is regaining prominence as a primary driver of economic value. The news underscores the sector’s resilience and the growing appetite for stability and tangible innovation in medical science, marking a notable pivot in global investment trends that may influence hiring priorities and strategic focus across industries.

Employer demand for Healthcare Management skills — indexed growth since 2019
Indicative index of skill mentions in professional job postings for the field this story moves (2019 = 1)
20191x20201.3x20211.9x20222.6x20233.8x20245.5x20257.8x202610.6x
Your move

What this means
for your career.

Every headline redistributes opportunity. Here is who this one rewards — and how to be on the right side of it.

This pivot suggests healthcare will offer greater career stability and growth opportunities than tech in the near term. You should prioritise skills in regulatory compliance, clinical operations, and biotech strategy. If you work in tech, consider how your expertise in data or AI applies to drug discovery and patient outcomes. Professionals in finance must now understand pharmaceutical valuation metrics. A smart move is to upskill in healthcare management or regulatory affairs immediately. Networking within pharma firms will become crucial as they expand. Do not ignore this trend; adapt your profile to highlight transferable skills relevant to health innovation. Position yourself as a bridge between traditional healthcare and modern technological solutions to remain highly employable.

For this story, the fields that convert it into pay are Healthcare Management, AI in Pharmaceuticals, Finance and Accounting and Regulatory Affairs — exactly the programmes matched below. The chart shows the indicative salary uplift certified professionals report in each of those fields; every one of them is a click away, from £79, finishing in as few as 20 days.

Indicative salary uplift in the fields matched to this story
Indicative ranges from published continuing-education salary studies, by field — each field is a recommended course below
Healthcare Management+24%AI in Pharmaceuticals+37%Finance and Accounting+32%Regulatory Affairs+20%

This briefing is based on reporting by Quartz on 15 Oct, 20:39. Read the original coverage →

Read the news. Then outrun it.

Every LSBR programme is online, self-paced and from £79 — so a headline today can be your credential this month.

What if one hour of learning today changed your career tomorrow?

Learn online, build expertise and keep moving forward — without putting your career on hold.

Chat with Admissions

LSBR School of Professional Development

Our admissions team is here to help you find the perfect programme.

Chat with AdmissionsGet guidance on courses, fees, entry requirements, and enrollment from our expert team.
Available 24/7 Our admissions consultants are always available to assist you with your queries.

Tell us about yourself to get started

Powered by LSBR